ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹100 Cr | ₹92 Cr | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr |
What is the latest Consolidated Net Profit of ORCHID PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹-1.95 Cr |
| Mar2021 | ₹-117 Cr |
How is Consolidated Net Profit of ORCHID PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 8.13 | |
| Mar2024 | ₹92 Cr | 98.99 | |
| Mar2023 | ₹46 Cr | Positive | |
| Mar2022 | ₹-1.95 Cr | Negative | |
| Mar2021 | ₹-117 Cr | - | |
Compare Consolidated Net Profit of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹4,882.4 Cr | -7.5% | -2.6% | 33.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -7.5% |
-2.6% |
33.7% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses